Goldman Sachs’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.37M Sell
602,013
-471,643
-44% -$6.47M ﹤0.01% 3210
2025
Q4
$14.8M Buy
1,073,656
+418,548
+64% +$9.84M ﹤0.01% 2674
2025
Q3
$16M Buy
655,108
+306,618
+88% +$7.47M ﹤0.01% 2478
2025
Q2
$8.05M Buy
348,490
+62,212
+22% +$1.64M ﹤0.01% 2961
2025
Q1
$7.73M Sell
286,278
-94,069
-25% -$3.55M ﹤0.01% 2929
2024
Q4
$20.4M Buy
380,347
+64,612
+20% +$3.42M ﹤0.01% 2117
2024
Q3
$14.3M Sell
315,735
-28,937
-8% -$1.26M ﹤0.01% 2359
2024
Q2
$14.4M Sell
344,672
-2,499
-0.7% -$117K ﹤0.01% 2160
2024
Q1
$13.1M Buy
347,171
+307,223
+769% +$6.69M ﹤0.01% 2233
2023
Q4
$429K Buy
39,948
+25,404
+175% +$220K ﹤0.01% 4846
2023
Q3
$147K Sell
14,544
-8,175
-36% -$94.3K ﹤0.01% 5112
2023
Q2
$270K Buy
+22,719
New +$304K ﹤0.01% 5061
2023
Q1
Sell
-14,603
Closed -$192K 6088
2022
Q4
$192K Buy
14,603
+556
+4% +$8.14K ﹤0.01% 5321
2022
Q3
$190K Sell
14,047
-1,817
-11% -$24.3K ﹤0.01% 5507
2022
Q2
$194K Sell
15,864
-2,070
-12% -$24.5K ﹤0.01% 5654
2022
Q1
$257K Buy
17,934
+3,186
+22% +$52.1K ﹤0.01% 5745
2021
Q4
$291K Buy
+14,748
New +$309K ﹤0.01% 5684
2021
Q3
Sell
-69,000
Closed -$1.72M 6367
2021
Q2
$1.72M Buy
+69,000
New +$1.54M ﹤0.01% 4339

Other funds holding JANX